Current issue
The Rockefeller University Board of Trustees
Chair
Russell L. Carson*
General Partner, Welsh, Carson, Anderson and Stowe
Mr. Carson co-founded Welsh, Carson, Anderson and Stowe, one of the largest private investment companies in the U.S., in 1979. Previously, he served as chair and CEO at Citicorp Venture Capital, Ltd. He is chair of the endowment for Inner-city Education, co-chair of Columbia Business School and co-chair of the New York City Investment Fund. He became interested in Rockefeller more than 15 years ago when his daughter was admitted to the hospital with psoriasis. "Our family developed a close relationship with Marty Carter and his successor Jim Krueger. As I learned more about Rockefeller, I became more and more impressed with both the world-class science that takes place at the university and the ability of that science to translate into knowledge that can have a major impact on the human condition. When I was asked to join the Board of Rockefeller I considered it one of the greatest honors of my life." He joined the Board in 1994.
Vice Chair
Richard E. Salomon*
President, Mecox Ventures, Inc.
Mr. Salomon serves as senior advisor to Honorary Chair David Rockefeller, who first introduced him to Rockefeller University in 1969. In 1982, he became a partner in the investment advisory firm, Spears, Benzak, Salomon and Farrell. Mr. Salomon joined the Rockefeller Board in 1984 at Mr. Rockefeller's invitation, and soon thereafter was asked to chair the investment committee. "I felt that was an area where I could contribute and at the same time be involved in the growth and evolution of Rockefeller," says Mr. Salomon. "While Rockefeller has seen lots of ups and downs over the last 35 years I'm proud of my association with this extraordinary institution. I don't always grasp all of the hard science, but I always come out of faculty presentations knowing that extraordinary things are going on in this place."
Vice Chair
David I. Hirsh, Ph.D.*
Executive Vice President for Research, Columbia University
Dr. Hirsh is a 1968 alumnus of Rockefeller University and his career has included prestigious appointments at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England; the University of Colorado and the College of Physicians and Surgeons at Columbia University. Previous to his current position at Columbia, Dr. Hirsh served as dean for research and professor and chair of the department of biochemistry and molecular biophysics. In 1980, he co-founded Synergen, a biotechnology company that developed proteins as therapeutics. Dr. Hirsh was elected to the Board of Rockefeller in 2001. He also serves as an advisor to Warburg Pincus and is on the boards of ZymoGenetics, Inc. and the Agouron Institute, a foundation devoted to supporting creative scientific research. He was elected to the Board in 2001.
Vice Chair
Henry R. Kravis*
Founding Partner, Kohlberg, Kravis, Roberts and Company
Mr. Kravis began his career at Katy Industries, where he designed the company's acquisition program. He later worked as a partner with Bear, Stearns and Company. In 1976 he and two colleagues from Bear, Stearns co-founded Kohlberg, Kravis, Roberts and Company, a merchant banking firm that pioneered the management buyout. Henry Kravis is a veteran of the mergers and acquisitions business and serves on numerous corporate boards. He also serves on the boards of the Partnership for New York City, The Metropolitan Museum of Art, Mount Sinai Medical Center, Thirteen/WNET, Columbia Business School and Claremont McKenna College. He was elected to the Board in 2004.
Vice Chair
Marnie S. Pillsbury*
Executive Director, David Rockefeller Fund, Rockefeller Financial Services, Inc.
Previous to her current position, Ms. Pillsbury was a special investments administrator at Rockefeller and Company and was director of program development at the Center for Public Resources. She is a trustee of World Learning and the Women's Campaign Fund, and is a member of the Council on Foreign Relations. She serves on the President's Council of the International Women's Health Coalition, the New York City Planned Parenthood Council of Advocates and the Committee on Prints and Illustrated Books at The Museum of Modern Art. Ms. Pillsbury was elected to the Rockefeller Board in 1998. "I came to appreciate that this unique institution with its extraordinary scientists could change people's lives and impact global health and the way people live all over the world," she says. "The potential for making important discoveries and broadening people's understanding of the power of science is very exciting."
Finance and Operations Committee
Willard J. Overlock Jr.,* chair
Senior Director, The Goldman Sachs Group, Inc.
Mr. Overlock, who goes by Mike, is an expert on mergers, acquisitions and takeovers. He joined Goldman Sachs in 1973 and became a partner in 1982. He has served in senior positions in both the mergers and acquisitions and investment banking departments, as well as the management and international executive committees. In addition to serving on the boards of academic institutions, Mr. Overlock is the former chair of the Juvenile Diabetes Research Foundation International. "My interest in medical research occurred when two of my children developed several chronic diseases, including asthma and type 1 diabetes, and a severe peanut allergy," says Mr. Overlock. "Rockefeller scientists are focused on the treatment and ultimate eradication of disease through outstanding medical and biological research. Rockefeller University has some of the best minds in the world working on these problems. I was interested in being a small part of this work." He joined the Board of Trustees in March 2004.
Peter A. Flaherty, vice chair
Michael D. Fascitelli*
Henry R. Kravis
Thomas H. Lee
Robin Neustein
Julian H. Robertson Jr.
D. Ronald Daniel+
John C. Whitehead+
Investment Committee
Sandra J. Horbach,* chair
Managing Director, The Carlyle Group
Ms. Horbach began her career with Morgan Stanley and Company, working in mergers and acquisitions. Forstmann Little, which she joined as an associate in 1987, is a New York-based private investment partnership that has invested in excess of $15 billion in 30 platform companies and 58 add-on acquisitions. She served there as general partner from 1993 to 2004, when she became a limited partner. In 2005, Ms. Horbach joined the global private equity firm The Carlyle Group as a managing director. Focused on U.S. buyout investment opportunities in the consumer and retail industries, she serves as the head of the Global Consumer and Retail team. Ms. Horbach is a member of the Stanford Business School Advisory Council and a trustee of the Chapin School in New York. She was elected to the Rockefeller Board in 2001.
James H. Simons, vice chair
Christopher H. Browne
Richard E. Salomon
Lulu C. Wang
D. Ronald Daniel+
John C. Whitehead+
Development Committee
Christopher H. Browne,* chair
Managing Director, Tweedy, Browne Company, LLC; General Partner, TBK Partners, LP; General Partner, Vanderbilt Partners, LP
Mr. Browne joined Tweedy, Browne, a privately owned investment banking firm, in 1969. He was introduced to Rockefeller by a colleague who told him of the work being done by the DirectEffect AIDS Research Support Program, the only such group devoting 100 percent of donations to actual research rather than overhead. "I was impressed with the quality of the research going on at the university. I especially liked the fact that the school has stayed with its mission to be the best it can in a select number of fields rather than trying to be a mega-research institution. I believe smaller can be better," says Mr. Browne. He is a trustee of The Institute of Classical Architecture and Classical America, the East Hampton Historical Society and the New York Council of The Brookings Institution. He was elected to the Rockefeller Board in 1997.
Marnie S. Pillsbury, vice chair
Judith Roth Berkowitz
Marlene Hess
Robin Neustein
Richard E. Salomon
Sydney R. Shuman
Frederick A. Terry Jr.
D. Ronald Daniel+
Alexander D. Forger+
Richard M. Furlaud+
John C. Whitehead+
Committee on Scientific Affairs
Joseph L. Goldstein, M.D., chair
Chair, Department of Molecular Genetics, University of Texas Southwestern Medical Center
Dr. Goldstein is a trustee of the Howard Hughes Medical Institute and is on the scientific advisory boards of Memorial Sloan-Kettering, The Welch Foundation and The Scripps Research Institute. With his colleague Michael Brown, he received the Albert Lasker Award in Basic Medical Research in 1985, the National Medal of Science in 1988 and the 1985 Nobel Prize in Physiology or Medicine, for discoveries on the regulation of cholesterol metabolism. Dr. Goldstein joined the Rockefeller Board in 1993. "Rockefeller has become a breeding ground for scientists of distinction, producing a scientific genealogy that no other biomedical institution can match," says Dr. Goldstein. "The goal of the committee on scientific affairs (COSA) is to work with the faculty to ensure the perpetuation of this 100-year tradition."
Edward J. Benz Jr.
David Botstein
Anthony B. Evnin
David I. Hirsh
Paul Nurse*
Eric R. Kandel+
David G. Nathan+
Non-trustee Members:
Tom Maniatis
Philippa Marrack
Hospital Committee
Edward J. Benz Jr., M.D., chair
President and CEO, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
An internationally recognized hematologist, Dr. Benz is an expert in inherited anemias and diseases of the red blood cell. He is a member of the Institute of Medicine of the National Academy of Sciences. He has served on numerous National Institutes of Health committees and currently co-chairs the NIH Advisory Board for Clinical Research. "Rockefeller is unique in the high percentage of absolutely outstanding investigators on the faculty," says Dr. Benz. "The university has by design elected to remain small. By focusing on a small faculty of world-class investigators, Rockefeller has been able to have a disproportionately large impact on the advances in our understanding of the basic biomedical aspects of human diseases. There is a lot that you can learn from an organization that has focused that way vertically, with a small number of truly excellent investigators, as opposed to other very good institutions that have tried to achieve the same thing through growth and over the years have become very large and complicated organizations." Dr. Benz was elected to the Board in 2004.
Allen R. Adler
Judith Roth Berkowitz
Joseph L. Goldstein
Nancy M. Kissinger
Evelyn G. Lipper
Richard G. Rockefeller
David G. Nathan+
Technology Transfer Committee
Anthony B. Evnin, Ph.D.,* chair
General Partner, Venrock Associates
Dr. Evnin received his Ph.D. in chemistry from Massachusetts Institute of Technology. In 1974 he joined Venrock Associates, formed in 1969 to manage the venture capital investments of the Rockefeller Family. Venrock today is a diversified fund investing in information technology and healthcare. He serves on the boards of Coley Pharmaceutical Group, Memory Pharmaceuticals, Renovis and numerous other healthcare companies as well as Princeton University. He is a co-chair of the Bridges to Better Medicine initiative, a Rockefeller organization that brings together the knowledge and resources of research scientists, venture capitalists, investors, analysts and biotech executives. "I was attracted to Rockefeller for the opportunity to interact with and be part of one of the finest biomedical research institutions in the world, doing groundbreaking work across the frontiers of biological science, with multiple impacts on medicine and human health. My background and interests in science and technology translation enable me to have a broad interaction at the University," says Dr. Evnin. He was elected to the Board in 1999.
Allen R. Adler
G. S. Beckwith Gilbert
Frank H. Pearl
Frederick A. Terry Jr.
Non-trustee Members:
David Elliman
Teena Lerner
Faculty Advisor:
Jeffrey M. Friedman+
Audit Committee
Peter A. Flaherty, chair
Managing Director, Arcon Partners, LLC
Arcon Partners is a private investment firm. Mr. Flaherty is also a director emeritus of McKinsey and Company, which he joined in 1975, working mainly with financial institutions and media and information companies. He is on the boards of U.S. Trust, Epoch Investment Partners, TechnoServe and the Foreign Policy Association and is a member of the Council on Foreign Relations. He is an alumnus of Stanford University, the Paul H. Nitze School of Advanced International Studies (SAIS) at Johns Hopkins University, and Harvard Business School. He serves on the advisory councils of the Institute for International Studies at Stanford and SAIS at Johns Hopkins. Mr. Flaherty was elected to the Rockefeller Board in 2003.
G. S. Beckwith Gilbert
Robin Neustein
Marnie S. Pillsbury
Compensation Committee
Russell L. Carson, chair
David I. Hirsh
Henry R. Kravis
Marnie S. Pillsbury
Richard E. Salomon
Nomination and Governance Committee
Richard E. Salomon, chair
Judith Roth Berkowitz
Christopher H. Browne
Henry R. Kravis
Willard J. Overlock Jr.
Marnie S. Pillsbury
Sydney R. Shuman
Educational Affairs Committee
David I. Hirsh, Ph.D., chair
Neva R. Goodwin
Marlene Hess
Nancy M. Kissinger
Evelyn G. Lipper
Non-trustee Member:
David D. Sabatini
Faculty Advisor:
John D. McKinney
* member of the Executive Committee
+ by invitation on a regular basis
April 14, 2006
|
